Mayo Overlap Between Sections 101 And 102/103 — Not New
In Mayo Collaborative Services v. Prometheus Laboratories Inc.,[1] the Supreme Court held patent claims directed to a method for administering a drug to optimize its therapeutic efficacy invalid under 35 U.S.C....To view the full article, register now.
Already a subscriber? Click here to view full article